Predicting stroke and mortality in mitral stenosis with atrial flutter: A machine learning approach

Amer Rauf1, Asif Ullah2, Usha Rathi3

  • 1Department of Electrophysiology, Armed Forces Institute of Cardiology, Rawalpindi, Pakistan.

Insights

A gradient boosting machine model accurately predicts stroke and mortality in mitral stenosis with atrial flutter by analyzing patient data. Key predictors include mitral valve area, pulmonary artery pressure, and ejection fraction.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Machine Learning in Medicine

Background:

  • Mitral stenosis (MS) with atrial flutter (AFL) presents complex risks for patients.
  • Predicting cerebrovascular events and mortality in this population is clinically significant.
  • Existing risk stratification methods may benefit from advanced analytical approaches.

Purpose of the Study:

  • To develop and validate a gradient boosting machine (GBM) model for predicting cerebrovascular events and all-cause mortality in patients with MS and AFL.
  • To identify key clinical, electrocardiographic, and echocardiographic predictors for these adverse outcomes.

Main Methods:

  • A machine learning approach using a gradient boosting machine (GBM) model.
  • Analysis of chart data and imaging studies from 2184 patients with MS and AFL.
  • Statistical analysis to identify significant risk factors and high-risk features.

Main Results:

  • GBM identified significant predictors for transient ischemic attack (TIA)/stroke: mitral valve area (MVA), right ventricular systolic pressure, pulmonary artery pressure (PAP), left ventricular ejection fraction (LVEF), New York Heart Association (NYHA) class, and surgery.
  • Predictors for all-cause mortality included MVA, PAP, LVEF, creatinine, hemoglobin, and diastolic blood pressure.
  • The model demonstrated effective risk prediction by recognizing key variables.

Conclusions:

  • The GBM model effectively integrates diverse clinical data for improved risk prediction in MS with AFL.
  • The model enhances the identification of critical variables associated with cerebrovascular events and mortality.
  • This approach offers a promising tool for risk stratification and clinical decision-making in this patient cohort.
Abstract

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
23
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
13
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
22
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
16
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
23
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
14